The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy.
D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D012008:Recurrence; D013450:Sulfones / Q000627:therapeutic use*
D013450:Sulfones; D003622:Dapsone; C009799:solasulfone